These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 7662044)
1. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Paille FM; Guelfi JD; Perkins AC; Royer RJ; Steru L; Parot P Alcohol Alcohol; 1995 Mar; 30(2):239-47. PubMed ID: 7662044 [TBL] [Abstract][Full Text] [Related]
2. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme. Poldrugo F Addiction; 1997 Nov; 92(11):1537-46. PubMed ID: 9519495 [TBL] [Abstract][Full Text] [Related]
3. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Whitworth AB; Fischer F; Lesch OM; Nimmerrichter A; Oberbauer H; Platz T; Potgieter A; Walter H; Fleischhacker WW Lancet; 1996 May; 347(9013):1438-42. PubMed ID: 8676626 [TBL] [Abstract][Full Text] [Related]
4. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation. Mason BJ; Goodman AM; Chabac S; Lehert P J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study. Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of acamprosate for the treatment of alcohol dependence long after recovery from withdrawal syndrome: a randomized, double-blind, placebo-controlled study conducted in Japan (Sunrise Study). Higuchi S; J Clin Psychiatry; 2015 Feb; 76(2):181-8. PubMed ID: 25742205 [TBL] [Abstract][Full Text] [Related]
7. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects. Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211 [TBL] [Abstract][Full Text] [Related]
8. Acamprosate: a new pharmacotherapeutic approach to relapse prevention in alcoholism--preliminary data. Soyka M; Sass H Alcohol Alcohol Suppl; 1994; 2():531-6. PubMed ID: 8974379 [TBL] [Abstract][Full Text] [Related]
9. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study. Soyka M; Preuss U; Schuetz C Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521 [TBL] [Abstract][Full Text] [Related]
10. Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects. Johnson BA; O'Malley SS; Ciraulo DA; Roache JD; Chambers RA; Sarid-Segal O; Couper D J Clin Psychopharmacol; 2003 Jun; 23(3):281-93. PubMed ID: 12826990 [TBL] [Abstract][Full Text] [Related]
12. Acamprosate appears to decrease alcohol intake in weaned alcoholics. Lhuintre JP; Moore N; Tran G; Steru L; Langrenon S; Daoust M; Parot P; Ladure P; Libert C; Boismare F Alcohol Alcohol; 1990; 25(6):613-22. PubMed ID: 2085344 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study. Pelc I; Verbanck P; Le Bon O; Gavrilovic M; Lion K; Lehert P Br J Psychiatry; 1997 Jul; 171():73-7. PubMed ID: 9328500 [TBL] [Abstract][Full Text] [Related]
14. Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study. Besson J; Aeby F; Kasas A; Lehert P; Potgieter A Alcohol Clin Exp Res; 1998 May; 22(3):573-9. PubMed ID: 9622434 [TBL] [Abstract][Full Text] [Related]
15. Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. Sass H; Soyka M; Mann K; Zieglgänsberger W Arch Gen Psychiatry; 1996 Aug; 53(8):673-80. PubMed ID: 8694680 [TBL] [Abstract][Full Text] [Related]
16. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy. Feeney GF; Connor JP; Young RM; Tucker J; McPherson A Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406 [TBL] [Abstract][Full Text] [Related]
17. The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Mann K; Lehert P; Morgan MY Alcohol Clin Exp Res; 2004 Jan; 28(1):51-63. PubMed ID: 14745302 [TBL] [Abstract][Full Text] [Related]
18. Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain. Gual A; Lehert P Alcohol Alcohol; 2001; 36(5):413-8. PubMed ID: 11524307 [TBL] [Abstract][Full Text] [Related]
19. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo. Dahl H; Hammarberg A; Franck J; Helander A Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946 [TBL] [Abstract][Full Text] [Related]
20. Effect of community nurse follow-up when treating alcohol dependence with acamprosate. Pelc I; Hanak C; Baert I; Houtain C; Lehert P; Landron F; Verbanck P Alcohol Alcohol; 2005; 40(4):302-7. PubMed ID: 15870092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]